HealthcareServices

Chromatin immunoprecipitation (ChIP) Sequencing Market Outlook: Growth and Forecast Highlights 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chromatin immunoprecipitation (chip) sequencing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Chromatin immunoprecipitation (ChIP) Sequencing Market show for the 2026–2030 period?

The market size for chromatin immunoprecipitation (chip) sequencing has experienced significant expansion recently. Projections indicate it will expand from $15.48 billion in 2025 to $17.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. This historical growth is due to factors such as the broadening of basic genomics research, an increase in academic research funding, the accessibility of next-generation sequencing platforms, a heightened interest in chromatin biology, and the proliferation of molecular biology laboratories.

The chromatin immunoprecipitation (chip) sequencing market size is anticipated to undergo significant expansion over the next few years, with projections indicating it will reach $29.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.6%. This expected growth during the forecast period is fueled by increasing investments in epigenomics research, the rising adoption of AI-driven genomic analysis, the expansion of precision medicine initiatives, a growing demand for multi-omics integration, and the increasing utilization of cloud-based bioinformatics platforms. Prominent trends observed in this period involve the rising application of genome-wide protein-DNA interaction mapping, the increasing embrace of high-throughput sequencing platforms, a growing need for epigenetics research tools, the development of integrated bioinformatics analysis pipelines, and an enhanced focus on regulatory genomics studies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp

What Drivers Are Shaping The Development Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?

The chromatin immunoprecipitation (ChIP) sequencing market is projected to expand due to the rising occurrence of prostate cancer. Prostate cancer is defined as a malignancy originating in the prostate gland, a small, walnut-shaped male organ responsible for producing seminal fluid. Within prostate cancer research, ChIP-seq provides an extensive understanding of the disease’s molecular mechanisms, delivering vital data crucial for comprehending its biology and creating more precise and efficient treatments. As an illustration, the American Cancer Society, a US-based organization dedicated to combating cancer, reported in January 2023 that approximately 288,300 new prostate cancer diagnoses and 34,700 fatalities attributed to the disease were estimated for 2023 in the US. Consequently, the expanding incidence of prostate cancer is fueling the expansion of the chromatin immunoprecipitation (ChIP) sequencing market.

What Segment Types Are Examined In The Chromatin immunoprecipitation (ChIP) Sequencing Market?

The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –

1) By Type: DNase-Sequencing, FAIRE-Sequencing

2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

4) By Application: Consumables And Reagents, Service, Other Applications

5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users

Subsegments:

1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions

2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions

What Trends Are Reshaping The Dynamics Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?

Leading entities within the chromatin immunoprecipitation (ChIP) sequencing market are directing their efforts towards pioneering technologies, including hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing), with the aim of elevating the precision and effectiveness of epigenomic studies, thereby propelling progress in drug discovery and personalized medicine. This hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) represents a sophisticated technological approach specifically developed to improve the investigation of epigenetic changes throughout the entire genome. An illustrative example is Epigenica, a life sciences technology firm located in Sweden, which introduced its EpiFinder Platform in June 2024. This platform incorporates patented hmqChIP-seq technology, facilitating high-throughput, multiplex quantitative analysis in epigenomic research. The groundbreaking platform empowers scientists to create 192 genome-wide profiles concurrently from a maximum of 24 samples, thereby optimizing extensive experiments with unmatched velocity and economic efficiency.

Who Are The Major Companies Operating In The Chromatin immunoprecipitation (ChIP) Sequencing Market?

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chromatin-immunoprecipitation-chip-sequencing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chromatin immunoprecipitation (ChIP) Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13265&type=smp

Browse Through More Reports Similar to the Global Chromatin immunoprecipitation (ChIP) Sequencing Market 2026, By The Business Research Company

Protein Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795